Лейкоцитоз и клинические исходы у больных инфарктом миокарда с подъемом сегмента ST

Литература:
1. Алекперов Э.З., Наджафов Р. Н. Современные концепции о роли воспаления при атеросклерозе // Кардиология. 2010. №6. С. 88-91; 2. Неспецифические маркеры воспаления в прогнозировании течения ишемической болезни сердца / Ф. Н. Палеев, И. С. Абудеева, О. В. Москалец [и др.] // Кардиология. 2009. № 9. С. 59-65; 3. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association / T.A. Pearson, G.A. Mensah, R.W. Alexander [etal.]//Circulation.2003. №107. P. 499-511; 4. Libby P., Ridker P. M., Hansson G. K. Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: from pathophysiology to practice // J.Am. Coll. Cardiol. 2009. №54. P. 2129-2138; 5. Asadollahi K., Beeching N.J., Gill G.V. Leukocytosis as a predictor for non-infective mortality and morbidity // Q. J. Med. 2010. №103. P. 285-292; 6. MadjidM.,Awanl.,WillersonJ.T.,CasscellsS.W. Leukocyte count and coronary heart disease. Implications for risk assessment // J.Am. Coll. Cardiol. 2004. № 44. P. 1945-1956; 7. Haim M., Boyko V., Goldbourt U., Battler A., Behar S. Predictive value of elevated white cell count in patients with preexisting coronary heart disease // Arch. Intern. Med.2004. №164. P. 433-439; 8. Coller B.S. Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene? // Arterioscler. Thromb. Vase. Biol. 2005. № 25. P. 658-670; 9. Asadollahi K., Beeching N.J., Gill G.V. Leukocytosis as a predictor for non-infective mortality and morbidity // Q. J. Med. 2010. №103. P. 285-292; 10. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularization: a systematic review on more than 34,000 subjects / L. Guasti, F. Dentali, i L. Castiglion [et al.] // Thromb. Haemost. 2011. №106. P. 591-599; 11. Polymorphonuclear leukocytes and high endothelin concentrations in acute coronary thrombi / С Adlbrecht, D. Bonderman, J. Jakowitch [et al.] // Eur. Heart J. 2003. № 24. P. 323; 12. Relation Between Leucocyte Count, Myonecrosis, Myocardial Perfusion, and Outcomes Following Primary Angioplasty / A. Prasad, G.W. Stone, ID. Stuckey [et al.] // American Journal of Cardiology. 2007. № 99 (8). P. 1067-1071; 13. Leukocytosis and adverse hospital outcomes after acute myocardial infarction / V. Menon, D. Lessard, J. Yarzebsk [et al.] //American Journal of Cardiology. 2003. № 92 (4). P. 368-372; 14. Mueller C, Neumann F.J., Perruchoud A. P., Buettner H. J. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularization // Heart. 2003. № 89. P. 389-392; 15. Hung M.J., Cherng W. J. Comparison of white cell count in acute myocardial infarction patients with significant and insignificant coronary artery disease //Am.J. Cardiol. 2003. №91. P. 1339-13342.